14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Nymox Pharmaceutical Corporation Stock and on which exchange is it traded?
The symbol for Nymox Pharmaceutical Corporation is NYMX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nymox Pharmaceutical Corporation Stock?
Nymox Pharmaceutical Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Nymox Pharmaceutical Corporation Stock?
Nymox Pharmaceutical Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nymox Pharmaceutical Corporation Stock.

What's the current price of Nymox Pharmaceutical Corporation Stock?
As of the end of day on the Nov 10, 2023, the price of an Nymox Pharmaceutical Corporation (NYMX) share was $0.200.

What is the 52-week high and low for Nymox Pharmaceutical Corporation Stock?
The 52-week high for Nymox Pharmaceutical Corporation Stock is $1.10 and the 52-week low is $0.170.

What is the market capitalization of Nymox Pharmaceutical Corporation Stock?
As of the Nov 10, 2023, the market capitalization of Nymox Pharmaceutical Corporation is 18.244M.
Click to get the best stock tips daily for free!

About Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinica... NYMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT